![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, January 18, 2020 9:45:03 PM
I believe a cream, even if less effective, that has few or no negative side effects will be well accepted by the market, and even insurance companies will be pleased with it if their cost is no greater than what they're currently paying.
I don't know if it's possible, but suspect that if Phase 2 data is strong enough, some regulatory authorities may approve the cream without requiring a Phase 3. I cannot say the U.S. FDA will be one of them, but even if only Israel made it available at first I believe it's use would rapidly grow as other regulators saw the benefits. Of course the key is the cream working, we should have an idea about that as they won't go into the blinded portion of the trial is benefits aren't seen in the initial part of the trial.
Gary
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM